Cargando…

A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson’s Disease

A paradigm shift has emerged in Parkinson’s disease (PD) highlighting the prominent role of CD4(+) Tregs in pathogenesis and treatment. Bench to bedside research, conducted by others and our own laboratories, advanced a neuroprotective role for Tregs making pharmacologic transformation of immediate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mosley, R. Lee, Lu, Yaman, Olson, Katherine E., Machhi, Jatin, Yan, Wenhui, Namminga, Krista L., Smith, Jenell R., Shandler, Scott J., Gendelman, Howard E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759633/ https://www.ncbi.nlm.nih.gov/pubmed/31619964 http://dx.doi.org/10.3389/fncel.2019.00421

Ejemplares similares

Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease
por: Markovic, Milica, et al.
Publicado: (2022)

Immunotherapy for Parkinson’s disease
por: Schwab, Aaron D., et al.
Publicado: (2020)

Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders
por: Machhi, Jatin, et al.
Publicado: (2020)

Immune senescence in aged APP/PS1 mice
por: Abdelmoaty, Mai M., et al.
Publicado: (2023)

An open-label multiyear study of sargramostim-treated Parkinson’s disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers
por: Olson, Katherine E., et al.
Publicado: (2023)

Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease
por: Abdelmoaty, Mai M., et al.
Publicado: (2022)

Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson's disease
por: Olson, Katherine E., et al.
Publicado: (2021)

Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson’s disease
por: Schutt, Charles R., et al.
Publicado: (2018)

URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer’s disease
por: Kiyota, Tomomi, et al.
Publicado: (2018)

CD4+ effector T cells accelerate Alzheimer’s disease in mice
por: Machhi, Jatin, et al.
Publicado: (2021)

Therapeutic Strategies for Immune Transformation in Parkinson’s Disease
por: Saleh, Maamoon, et al.
Publicado: (2022)

Prodrug Therapies for Infectious and Neurodegenerative Diseases
por: Markovic, Milica, et al.
Publicado: (2022)

Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions
por: Abdelmoaty, Mai M., et al.
Publicado: (2021)

Humanized Mice for Infectious and Neurodegenerative disorders
por: Dash, Prasanta K., et al.
Publicado: (2021)

CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 Elimination
por: Herskovitz, Jonathan, et al.
Publicado: (2021)

Adaptive Immune Neuroprotection in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice
por: Banerjee, Rebecca, et al.
Publicado: (2008)

The Immunopathobiology of SARS-CoV-2 Infection
por: Patel, Milankumar, et al.
Publicado: (2021)

Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders
por: Anderson, Kristi M, et al.
Publicado: (2014)

Vascular Smooth Muscle Cell Stiffness and Adhesion to Collagen I Modified by Vasoactive Agonists
por: Hong, Zhongkui, et al.
Publicado: (2015)

Vasoactive intestinal peptide producing pheochromocytoma and intracardiac thrombosis
por: Hermel, Melody, et al.
Publicado: (2021)

Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson’s disease trial
por: Gendelman, Howard E., et al.
Publicado: (2017)

Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues
por: Kevadiya, Bhavesh D., et al.
Publicado: (2020)

Regulation of Dopamine Uptake by Vasoactive Peptides in the Kidney
por: Rukavina Mikusic, N. L., et al.
Publicado: (2016)

Europium sulfide nanoprobes predict antiretroviral drug delivery into HIV-1 cell and tissue reservoirs
por: Herskovitz, Jonathan, et al.
Publicado: (2021)

CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease
por: Saunders, Jessica A. Hutter, et al.
Publicado: (2012)

Assessment of the vasoactive effects of the (S)-epimers of ergot alkaloids in vitro
por: Cherewyk, Jensen E, et al.
Publicado: (2020)

Allele‐specific cis‐regulatory methylation of the gene for vasoactive intestinal peptide in white‐throated sparrows
por: Prichard, Mackenzie R., et al.
Publicado: (2022)

The Neuroprotective Effects of the CB2 Agonist GW842166x in the 6-OHDA Mouse Model of Parkinson’s Disease
por: Yu, Hao, et al.
Publicado: (2021)

Potential Benefits of Therapeutic Use of β2-Adrenergic Receptor Agonists in Neuroprotection and Parkinsonμs Disease
por: Peterson, Lynda, et al.
Publicado: (2014)

The cortical signature of symptom laterality in Parkinson's disease
por: Heinrichs-Graham, Elizabeth, et al.
Publicado: (2017)

Vasoactive Hormones and the Diabetic Kidney
por: Maric, Christine
Publicado: (2008)

Weaning order of vasoactive drugs
por: Michels, Vilto, et al.
Publicado: (2019)

Neuromagnetic Evidence of Abnormal Movement-Related Beta Desynchronization in Parkinson's Disease
por: Heinrichs-Graham, Elizabeth, et al.
Publicado: (2014)

Corrigendum to: Assessment of the vasoactive effects of the (S)-epimers of ergot alkaloids in vitro
por: Cherewyk, Jensen E, et al.
Publicado: (2021)

The Promise of Neuroprotective Agents in Parkinson’s Disease
por: Seidl, Stacey E., et al.
Publicado: (2011)

Comparison of vasoactive-inotropic score, vasoactive-ventilation-renal score, and modified vasoactive-ventilation-renal score for predicting the poor prognosis after coronary artery bypass grafting
por: Du, Yanping, et al.
Publicado: (2023)

1110. Age-related effects of dexmedetomidine, an alpha-2 agonist, on coronary vasoactivity and cardiac function in guinea-pig hearts
por: Hongo, M, et al.
Publicado: (2014)

Multidimensional protein fractionation using ProteomeLab PF 2D™ for profiling amyotrophic lateral sclerosis immunity: A preliminary report
por: Schlautman, Joshua D, et al.
Publicado: (2008)

A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy
por: Araínga, Mariluz, et al.
Publicado: (2017)

Neuroprotective Potential of Peroxisome Proliferator Activated Receptor-α Agonist in Cognitive Impairment in Parkinson's Disease: Behavioral, Biochemical, and PBPK Profile
por: Uppalapati, Dedeepya, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9n9pduo2598dr6vmlr25cg3amh